GERON CORP — Director's Dealing 2021

Feb 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GERON CORP (GERN)
CIK: 0000886744
Period of Report: 2021-02-02

Reporting Person: Rizo Aleksandra (EVP, Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-02	Employee Stock Option (right to buy)	$2.055	A	300000	Acquired	2031-02-01	Common Stock (300000)	Direct

Footnotes

F1: This option vests in a series of 48 consecutive equal monthly installments commencing February 2, 2021, provided the optionee continues to provide services to the Company.